Loading stock data...

Transchem Limited

BSE: TRANSCHEM

BSE
48.92 1.43 (3.01%)

Prev Close

47.49

Open Price

48.45

Volume

15,511

Today Low / High

44.9 / 49.48

52 WK Low / High

31.1 / 58

Range

46 - 51

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 48.92, reflecting a change of 1.43 (3.01116%). The expected target range on the BSE is 46 - 51. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.

22 Aug 48.45 0.97%
21 Aug 47.15 0.72%
20 Aug 39.70 17.61%
19 Aug 40.99 -3.22%
18 Aug 40.00 -1.55%
14 Aug 39.50 0.23%
13 Aug 40.72 -3.76%
12 Aug 40.12 -1.37%
11 Aug 45.85 -12.50%
08 Aug 40.65 -0.30%
07 Aug 41.66 -2.83%
06 Aug 42.75 -0.21%
05 Aug 40.50 1.98%
04 Aug 41.14 0.00%
01 Aug 42.30 -0.50%
31 Jul 41.79 1.77%
30 Jul 41.40 1.43%
29 Jul 42.00 -0.62%
28 Jul 41.90 -3.79%

Transchem Limited Graph

Transchem Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Transchem Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 48.92, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 48.92 49.41 44.47 - 54.35
49.90 39.92 - 59.88
50.39 35.27 - 65.50
Bearish Scenario 48.92 48.43 43.59 - 53.27
47.94 38.35 - 57.53
47.45 33.22 - 61.69

Overview of Transchem Limited

ISIN

INE019B01010

Industry

Medical - Pharmaceuticals

Vol.Avg

4,220

Market Cap

598,780,800

Last Dividend

0

Official Website

Visit Website

IPO Date

2000-02-16

DCF Diff

32.95

DCF

7

Financial Ratios Every Investor Needs

Stock Rating Details for TRANSCHEM

Metric Value Recommendation
Overall Rating B+ Neutral
DCF Score 3 Neutral
ROE Score 4 Buy
ROA Score 4 Buy
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 2 Sell
Price-to-Book (PB) Score 4 Buy

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 2.63 Cr 2.61 Cr -0.65 Cr -0.2489 0.00 Cr 0.00 Cr -0.65 Cr 5.23 Cr 4.27 -1.46 Cr 1.9867
2024-03-31 0.41 Cr 1.16 Cr -0.75 Cr -1.8346 0.00 Cr 0.67 Cr -1.72 Cr 4.20 Cr 3.43 5.66 Cr 10.2522
2023-03-31 0.00 Cr 0.71 Cr -0.71 Cr 0.0000 0.00 Cr 0.62 Cr -1.74 Cr 1.24 Cr 1.01 -1.56 Cr 0.0000
2022-03-31 0.00 Cr 0.69 Cr -0.69 Cr 0.0000 0.00 Cr 1.52 Cr -2.75 Cr 2.87 Cr 2.34 -1.56 Cr 0.0000
2021-03-31 0.00 Cr 0.81 Cr -0.81 Cr 0.0000 0.21 Cr 0.56 Cr -2.06 Cr 24.15 Cr 19.73 24.89 Cr 0.0000

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 42.34 Cr 79.73 Cr 0.41 Cr 79.3154 Cr 0.00 Cr -42.34 Cr 0.00 Cr 0.05 Cr 0.00 Cr 0.00 Cr 2.04 Cr 0.3011 Cr
2024-03-31 0.32 Cr 76.32 Cr 0.67 Cr 75.6460 Cr 0.00 Cr -0.32 Cr 0.00 Cr 0.09 Cr 0.00 Cr 0.00 Cr 8.91 Cr 0.4790 Cr
2023-03-31 34.50 Cr 66.23 Cr 0.39 Cr 65.8422 Cr 0.00 Cr -34.50 Cr 0.00 Cr 0.09 Cr 0.00 Cr 0.00 Cr 8.23 Cr 0.0898 Cr
2022-03-31 34.22 Cr 66.81 Cr 0.51 Cr 66.3004 Cr 0.00 Cr -34.22 Cr 0.15 Cr 0.10 Cr 0.00 Cr 0.00 Cr 8.82 Cr 0.2796 Cr
2021-03-31 11.71 Cr 63.42 Cr 0.48 Cr 62.9415 Cr 0.00 Cr -11.71 Cr 0.07 Cr 0.11 Cr 0.00 Cr 0.00 Cr 8.69 Cr 0.2553 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 36.0003 Cr 6.0237 Cr 0.0000 Cr 35.9976 Cr 42.0240 Cr 42.3403 Cr -0.0027 Cr 5.2259 Cr 0.0000 Cr 0.0000 Cr 0.0000 Cr
2024-03-31 -39.3063 Cr 5.1236 Cr 0.0000 Cr -39.3093 Cr -34.1827 Cr 0.3163 Cr -0.0030 Cr 4.2034 Cr 0.0000 Cr 0.0000 Cr 0.0000 Cr
2023-03-31 1.2192 Cr -0.9406 Cr 0.0000 Cr 1.2192 Cr 0.2786 Cr 34.4990 Cr 0.0000 Cr 2.5041 Cr 0.0000 Cr 0.0000 Cr 0.1503 Cr
2022-03-31 21.9093 Cr 0.6004 Cr 0.0000 Cr 21.9093 Cr 22.5097 Cr 34.2204 Cr 0.0000 Cr 3.9082 Cr 0.0000 Cr 0.0000 Cr -0.0825 Cr
2021-03-31 -27.7193 Cr 23.0584 Cr 0.0000 Cr -27.8013 Cr -4.6609 Cr 11.7107 Cr -0.0820 Cr 24.7696 Cr 0.0000 Cr 0.0000 Cr 0.0175 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-03-31 2.42 Cr 2.40 Cr 0.02 Cr 0.0080 -0.19 Cr 0.73 Cr 0.60 -0.48 Cr 0.3010
2024-12-31 0.21 Cr 0.34 Cr -0.14 Cr -0.6578 -0.34 Cr 1.39 Cr 1.13 1.86 Cr 6.7447
2024-09-30 0.00 Cr 0.16 Cr -0.16 Cr 0.0000 -0.37 Cr 1.44 Cr 1.18 1.94 Cr 0.0000
2024-06-30 0.00 Cr 0.00 Cr 0.00 Cr 0.0000 -0.16 Cr 1.66 Cr 1.36 -0.27 Cr 0.0000
2024-03-31 0.41 Cr 0.64 Cr -0.23 Cr -0.5529 -0.46 Cr 1.25 Cr 1.02 1.71 Cr 3.0583

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-03-31 42.34 Cr 0.00 Cr 42.34 Cr 2.71 Cr 0.00 Cr 77.64 Cr 0.05 Cr 79.73 Cr 0.41 Cr
2024-12-31 0.00 Cr 0.00 Cr 0.34 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -77.30 Cr
2024-09-30 0.34 Cr 1.57 Cr 1.90 Cr 70.37 Cr 0.00 Cr 72.31 Cr 0.08 Cr 77.99 Cr 0.69 Cr
2024-06-30 -0.32 Cr 0.63 Cr 0.32 Cr 0.00 Cr 0.00 Cr 0.32 Cr 0.00 Cr 0.00 Cr -75.65 Cr
2024-03-31 0.32 Cr 1.56 Cr 0.32 Cr 67.01 Cr 0.00 Cr 67.33 Cr 0.09 Cr 76.32 Cr 0.67 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-03-31 0.73 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 1.39 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 1.44 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 1.66 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-03-31 1.25 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Pharmaceuticals

Company Name Symbol Price Market Cap Volume
MedPlus Health Services Limited MEDPLUS ₹821.25 ₹98,339,283,675.00 ₹72,992.00

Key Executives

Compliance Officer & Company Secretary
Ms. Neeraja Deepak Karandikar

Gender: female

Year Born: 1968

Chief Financial Officer
Ms. Sarita Maharao

Gender: female

Year Born:

Whole Time Director
Mr. Mahesh Suresh Rananavre

Gender: male

Year Born: 1982

FAQs about Transchem Limited

Who is the CEO of the company?

The CEO is Mahesh Suresh Rananavre.

What is the current market price of the stock?

The current price is ₹48.92.

What is the 52-week price range?

The range is ₹31.1-58.

What is the market capitalization of the company?

The market capitalization is ₹59.88 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 11.39.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Transchem Limited (ISIN: INE019B01010) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹59.88 crores and an average daily volume of 4,220 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.

Welcome to the Investing and Trading Information platform: InvesTrack.in

Note: This platform is for educational and informational purposes only. Do not consider anything as financial advice.

QUICK LINKS

Home
About us
Contact us
Privacy Policy
Disclaimer
Sitemap
Investing
Trading
Top Brokers
Tools
Live Analysis

STAY CONNECTED

Follow Us On Social Media
Get Latest Update On Social Media
Facebook Instagram Twitter

General Disclaimer: InvesTrack is an educational platform and not any type of investment advisory platform. Our Blog and videos are based on countless hours of research and experience, which you can use as a guide for your research purposes. None of our content should be considered a piece of investment advice. Earning Disclosure: InvesTrack is a community supported platform. We may earn a commission when you make a purchase through one of our links at no extra cost to you. Note: We are not SEBI Registered Advisors. This website is purely for training and educational purposes. We shall not be responsible for your profit or loss.

© Copyright 2024 - 2025 | InvesTrack